3.43
Goodrx Holdings Inc stock is traded at $3.43, with a volume of 610.62K.
It is up +2.08% in the last 24 hours and up +1.18% over the past month.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.
See More
Previous Close:
$3.36
Open:
$3.36
24h Volume:
610.62K
Relative Volume:
0.80
Market Cap:
$1.17B
Revenue:
$787.89M
Net Income/Loss:
$20.56M
P/E Ratio:
58.63
EPS:
0.0585
Net Cash Flow:
$96.54M
1W Performance:
+2.08%
1M Performance:
+1.18%
6M Performance:
+56.62%
1Y Performance:
-19.67%
Goodrx Holdings Inc Stock (GDRX) Company Profile
Name
Goodrx Holdings Inc
Sector
Industry
Phone
(855) 268-2822
Address
2701 OLYMPIC BOULEVARD, SANTA MONICA
Compare GDRX vs VEEV, TEM, BTSG, HNGE, HQY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
GDRX
Goodrx Holdings Inc
|
3.43 | 1.17B | 787.89M | 20.56M | 96.54M | 0.0585 |
|
VEEV
Veeva Systems Inc
|
296.13 | 47.95B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
TEM
Tempus Ai Inc
|
70.93 | 12.88B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
BTSG
Brightspring Health Services Inc
|
63.74 | 12.61B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
HNGE
Hinge Health Inc
|
102.90 | 8.30B | 646.34M | -512.40M | 202.76M | -6.6871 |
|
HQY
Healthequity Inc
|
92.61 | 7.66B | 1.34B | 230.70M | 440.96M | 2.6695 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-27-26 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-22-26 | Downgrade | Jefferies | Buy → Hold |
| Dec-09-25 | Initiated | Barclays | Underweight |
| Aug-11-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Aug-09-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| May-23-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-16-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Jan-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-10-23 | Upgrade | DA Davidson | Neutral → Buy |
| Jul-31-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Dec-01-22 | Initiated | Citigroup | Buy |
| Nov-04-22 | Upgrade | JP Morgan | Underweight → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-12-22 | Initiated | DA Davidson | Neutral |
| Jun-10-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-06-22 | Resumed | BofA Securities | Buy |
| Jun-01-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-10-22 | Downgrade | Evercore ISI | Outperform → In-line |
| May-10-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| May-10-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-10-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-11-22 | Initiated | Wells Fargo | Equal Weight |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-15-22 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-22 | Reiterated | Barclays | Overweight |
| Mar-01-22 | Reiterated | BofA Securities | Neutral |
| Mar-01-22 | Downgrade | Cowen | Outperform → Market Perform |
| Mar-01-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Mar-01-22 | Reiterated | Evercore ISI | Outperform |
| Mar-01-22 | Reiterated | Goldman | Buy |
| Mar-01-22 | Reiterated | JP Morgan | Underweight |
| Mar-01-22 | Reiterated | RBC Capital Mkts | Outperform |
| Mar-01-22 | Reiterated | SVB Leerink | Outperform |
| Jan-07-22 | Initiated | Goldman | Buy |
| Dec-21-21 | Initiated | Stephens | Overweight |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Aug-31-21 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-13-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-06-21 | Resumed | Evercore ISI | Outperform |
| Jan-25-21 | Initiated | Guggenheim | Buy |
| Nov-19-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-19-20 | Initiated | Barclays | Equal Weight |
| Oct-19-20 | Initiated | BofA Securities | Neutral |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-19-20 | Initiated | Cowen | Outperform |
| Oct-19-20 | Initiated | Credit Suisse | Outperform |
| Oct-19-20 | Initiated | Deutsche Bank | Hold |
| Oct-19-20 | Initiated | Goldman | Neutral |
| Oct-19-20 | Initiated | JP Morgan | Neutral |
| Oct-19-20 | Initiated | Morgan Stanley | Overweight |
| Oct-19-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-19-20 | Initiated | SVB Leerink | Outperform |
| Oct-19-20 | Initiated | UBS | Buy |
View All
Goodrx Holdings Inc Stock (GDRX) Latest News
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc. (GDRX) Investors - Lelezard
GoodRx Holdings (NasdaqGS:GDRX) Stock Forecast & Analyst Predictions - Simply Wall Street
GoodRx CFO Justin Fengler Reports RSU Vesting and Share Withholding on September 15, 2026 - Kalkine Media
GoodRx CAO Thomas Chan Reports RSU Vesting and Tax-Related Share Withholding on September 15, 2026 - Kalkine Media
GoodRx (GDRX) exec converts RSUs and withholds shares for taxes - Stock Titan
GoodRX’s $32 Million Data-Sharing Settlement Wins Initial Nod - Bloomberg Law News
AIAI Stock Price, Quote & News - Syfe
TaskUs, Inc. Class A (TASK) Stock Price & News - Syfe
InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - Investing.com Australia
InvestingPro Fair Value delivers 64% return on GoodRx in 5 months By Investing.com - investing.com
GoodRx offers health subscription for families, to launch as employee benefit in 2027 - reuters.com
GDRX Looks 34.8% Undervalued on GF Value™ - GuruFocus
One plan covers kids, adults and pets. GoodRx's new membership costs $24.99 a month. - Stock Titan
Promising Penny Stocks To Consider In August 2026 - simplywall.st
Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ) and GoodRx Holdings (GDRX) - The Globe and Mail
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com Nigeria
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com India
Major GoodRx (NASDAQ: GDRX) holder reshapes stake via conversion and sale - Stock Titan
GoodRx (NASDAQ:GDRX) 10% owner Francisco Partners sells $5.48m in stock - Investing.com
GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Moomoo
GoodRx Stock (GDRX) Opinions on TrumpRx Partnership - Quiver Quantitative
GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingROE Trend Analysis - vinanet.vn
GoodRx (GDRX) Results Breakdown: The Available Scorecard Is Mostly Near Expectations in the Current Update; Share Move: Shares Close 3.09% Lower in Latest TradingProfit Announcement - vinanet.vn
GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com Australia
GoodRx 10% owner Francisco Partners sells $4.2m in shares By Investing.com - Investing.com India
GDRX Maintains Underweight Rating -- Price Target Raised to $4.0 - GuruFocus
Q2 2026 GoodRx Holdings, Inc. Earnings Call Transcript - GuruFocus
GoodRx 10% owner Francisco Partners sells $4.2m in shares - Investing.com
GoodRx(GDRX.US) 10% Shareholder Sells US$4.2 Million in Common Stock - Moomoo
Justin Fengler Net Worth (2026) - GuruFocus
Big GoodRx (NASDAQ: GDRX) backer prepares share sale - Stock Titan
Technology Crossover Management X Ltd. Buys Shares of 1,653,566 GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move - vinanet.vn
GoodRx (GDRX) Results at a Glance: The Available Figures Are Largely Near Expectations at the Close; Stock Move: Shares Move Lower 1.88% in Latest TradingShare Repurchase Impact - siam.in
GoodRx Holdings Inc (GDRX) (Q2 2026) Earnings Call Highlights: R - GuruFocus
GoodRx (NASDAQ:GDRX) Rating Increased to Buy at Wall Street Zen - MarketBeat
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - Yahoo Finance
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Rating of "Hold" from Brokerages - MarketBeat
GDRX Maintained by UBS -- Price Target Raised to $3.75 - GuruFocus
GoodRx (GDRX) Stock Looks Overvalued On Its Earnings Outlook - Yahoo Finance
GoodRx Holdings (GDRX) Could Be 13% Overvalued After Q2 Earnings and Guidance Raise - Yahoo Finance
GoodRx (GDRX) Stock Trades At A Premium On Earnings Despite Weak Returns - webull.com
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Motley Fool
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - AOL.com
GoodRx (NASDAQ:GDRX) Trading Down 5.1%What's Next? - MarketBeat
GoodRx: Direct Brand Launches And New Subscription Plans Are Offering Hope (NASDAQ:GDRX) - Seeking Alpha
GoodRx (GDRX) Q2 2026 Earnings Call Transcript - The Globe and Mail
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX) - The Globe and Mail
GDRX Maintained by Citigroup -- Price Target Raised to $5.00 - GuruFocus
Goodrx Holdings Inc Stock (GDRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Goodrx Holdings Inc Stock (GDRX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| FRANCISCO PARTNERS IV, L.P. | 10% Owner |
Aug 25 '26 |
Sale |
3.44 |
127,273 |
438,443 |
643,466 |
| FRANCISCO PARTNERS IV, L.P. | 10% Owner |
Aug 24 '26 |
Sale |
3.46 |
143,594 |
497,122 |
706,649 |
| FRANCISCO PARTNERS IV, L.P. | 10% Owner |
Aug 21 '26 |
Sale |
3.50 |
274,717 |
960,630 |
777,213 |
| FRANCISCO PARTNERS IV, L.P. | 10% Owner |
Aug 20 '26 |
Sale |
3.52 |
447,259 |
1,574,575 |
913,592 |
| Francisco Partners GP IV, L.P. | 10% Owner |
Aug 19 '26 |
Proposed Sale |
3.72 |
2,760,995 |
10,270,901 |
0 |
| FRANCISCO PARTNERS IV, L.P. | 10% Owner |
Aug 19 '26 |
Sale |
3.53 |
471,975 |
1,666,025 |
1,127,436 |
| IAN THORNTON CLARK | Director |
May 13 '26 |
Proposed Sale |
2.59 |
43,100 |
111,620 |
0 |
| REY-GIRAUD AGNES | Director |
Mar 12 '26 |
Option Exercise |
0.47 |
192,185 |
90,327 |
277,633 |
| Spectrum Equity VII, L.P. | 10% Owner |
Oct 15 '25 |
Sale |
4.00 |
23,771 |
95,103 |
0 |
| Spectrum VII Co-Investment Fun | Affiliate |
Oct 15 '25 |
Proposed Sale |
4.02 |
8,569 |
34,447 |
0 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):